News

Yahoo Finance2y
Aridis Reports Top-Line Results of the Phase 3 Double-Blinded, Superiority Trial of AR-301 For the Treatment of Staphylococcus aureus Ventilator Associated Pneumonia (VAP)
LOS GATOS, Calif, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced top-line results from the AR-301-002 Phase 3 study, which evaluated the superiority ...
The New England Journal of Medicine8y
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
The trial protocols were approved by the institutional review board or ethics committee ... randomized, double-blind, placebo-controlled phase 3 trials; an active drug control was also included ...
Yahoo Finance4y
Anavex Life Sciences Reports the Results of Review by the Independent Data Safety Monitoring Board for its Phase 2/3 Trials of ANAVEX®2-73 in Patients with Rett Syndrome
Upon review of the interim safety data, the DSMB made the following recommendation for the randomized, double-blind ... controlled U.S. Phase 2 (ANAVEX®2-73-RS-001) 3 study in adult patients ...
ascopubs.org10y
SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma
The SEARCH (Sorafenib and Erlotinib, a Randomized Trial Protocol for the Treatment of Patients With Hepatocellular Carcinoma) study was a randomized, double-blind, placebo-controlled, phase III trial ...
ascopubs.org2y
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma
T-VEC was administered at ≤ 4 × 10 6 plaque-forming unit (PFU) followed by ≤ 4 × 10 8 PFU 3 weeks later and once ... This randomized, double-blinded, placebo-controlled, multicenter, international ...